참고문헌
- Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine 1981;60:413-28 https://doi.org/10.1097/00005792-198111000-00003
- Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600 https://doi.org/10.1056/NEJMra020528
- Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001;60:831–46 https://doi.org/10.1046/j.1523-1755.2001.060003831.x
- Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 1989:87:9-15 https://doi.org/10.1016/0002-9343(89)90011-9
- Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic hemolyticuremic syndrome. N Engl J Med 1998;339:1578–84 https://doi.org/10.1056/NEJM199811263392202
- Kremer Hovinga JA, Studt JD, Lammle B. The von Willebrand factor cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Pathophysiol Haemost Thromb Sep 2003–Dec 2004;33:417–21
- Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403 https://doi.org/10.1056/NEJM199108083250605
- Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United Statesanalysis of national mortality data, 1968-1991. Am J Hematol 1995;50:84-90 https://doi.org/10.1002/ajh.2830500203
- Allford SL, Hunt BJ, Rose P, Machin SJ. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120:556–73 https://doi.org/10.1046/j.1365-2141.2003.04049.x
- Ashida A, Nakamura H, Yoden A, Tamai H, Ishizashi H, Vagi H, et al. Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw–Schulman syndrome. Am J Hematol 2002;71: 318–22 https://doi.org/10.1002/ajh.10228
- Schneppenheim R, Budde U, Oyen F, Angerhaus D, Aumann V, Drewke E, et al. Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 2003;101:1845–50 https://doi.org/10.1182/blood-2002-08-2399
- Horton TM, Stone JD, Yee D, Dreyer Z, Moake JL, Mahoney DH. Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol 2003;25:336–9 https://doi.org/10.1097/00043426-200304000-00016
- Moake JL, Turner WA, Stathopoulos NA, Norlasco L, Hellums JD. Involvement of large plasma vWF forms derived from endothelial cells in shear stress induced platelet aggregation. Clin Invest 1986;78:1456-61 https://doi.org/10.1172/JCI112736
- Tsai HM. Physiologic cleavage of vWF by a plasma protease dependent on its conformation and requires ion. Blood 1996;87:4235-44
- Tsai HM. The molecular biology of thrombotic microangiopathy. Kidney Int 2006;70:16–23 https://doi.org/10.1038/sj.ki.5001535
- Sadler JE, Moake JL, Miyata T, George JN. Recent advances in thrombotic thrombocytopenic purpura. Hematology 2004;407–23
- George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927–35 https://doi.org/10.1056/NEJMcp053024
- Mannuci PM, Vanoli M, Forza I, Canciani MT, Scorza R. Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue disease (systemic lupus erythemaotosus and systemic sclerosis). Haematologica 2003;88:914-8
- Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992;326:1373–9 https://doi.org/10.1056/NEJM199205213262101
- Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh T, et al. Systemic lupus erythemotosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 2003;22:355-8 https://doi.org/10.1007/s10067-003-0742-1
피인용 문헌
- Von Willebrand Factor-Cleaving Protease Activity in Thrombotic Microangiopathy: First Report From Iran vol.6, pp.6, 2014, https://doi.org/10.5812/numonthly.18900